The Central Dogma Multiomics Company™

Capillary Blood Experts. One Assay. Endless Possibilities.

Explore the entire human genome, transcriptome, and thousands of proteins with high specificity, transparent data, and the flexibility to answer any research question. Meet the next-generation longitudinal capillary multiomics assay trusted by the scientific community, from small academic research teams to leading pharma companies.

That's LCM™ - Longitudinal Capillary Multiomics ™

Intellectual Property, Trademarks and Patents

Our core IP rests on the following unique and innovative technologies exclusive to TimepointDx:
1. Longitudinal Capillary Multiomics™ (LCM™)
2. Capillary Stem Cell Reprogramming™ (CSCR™)
3. Aggregated Longitudinal Sequencing™ (ALseq™)
4. Capillary In Vitro Clinical Trials™ (CIVCT™)
5. Combinatorial Multiomics Libraries™ (CML™)
Through our core IP, we've derived hundreds of LCM™ derivatives and applications (100+ and counting). We're exclusively focused on liquid capillary and fenestrated blood samples as the primary sample, with LCM™ included as standard of practice for every sample.

Contact Us To Learn More